Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Multichannel automatic foetal movement monitoring and classification system

    The purpose of this work was to develop a compact, noninvasive and objective tool for foetal movement monitoring and classification. Four tocodynamometers were used as movement transducers and their output sig...

    I. Florentin, G. F. Inbar in Medical and Biological Engineering and Com… (1985)

  2. No Access

    Article

    Anin vitro effect of an acute non-specific inflammatory serum on rat lymphocytes proliferative response to PHA

    This study has demonstrated that serum obtained from animals undergoing an acute inflammatory reaction induced by an intrapleural injection of dextran is able to modulate the proliferative response to PHA of l...

    Yao ** Sheng, I. Florentin, J. Bird, P. Michel, A. Pompidou in Agents and Actions (1984)

  3. No Access

    Article

    Antitumor activity of living or killed Brucella: Modification of the non-specific cytotoxic effector cells

    At various times after injection of living or killed smooth (S) or rough (R) Brucella abortus mice received a graft of the semi-allogenic EL4 lymphoma and their survival was studied. In parallel, the NK activity ...

    L. Dazord, Y. le Garrec, I. Florentin in Cancer Immunology, Immunotherapy (1983)

  4. No Access

    Chapter

    Effect of Chronic Administration of a Synthetic Aromatic Retinoid (Ro 10-9359) on the Development of Lung Squamous Metaplasia and Epidermoid Cancer in Rats

    Since the first studies of Saffioti et al. (1) suggesting the preventive effect of high doses of vitamin A on squamous metaplasias of trachea and bronchis, several authors have used synthetic analogs of vitami...

    D. Nolibe, R. Masse, J. Lafuma, I. Florentin in Biological Response Modifiers in Human Onc… (1983)

  5. No Access

    Chapter

    Three New Agents for Immunotherapy Trials: Azimexon, Bestatin, and Tuftsin

    Cancer immunotherapy trials in man have almost exclusively been conducted with BCG, C. parvum, and MER (methanol extract residue of BCG)]19]. Not only did the clinical researchers meet difficulties concerning tol...

    G. Mathé, I. Florentin, M. Bruley-Rosset, A. Goutner in Adjuvant Therapies of Cancer (1982)

  6. No Access

    Article

    Macrophage activation by tuftsin and muramyl-dipeptide

    Peritoneal macrophages from tuftsin or MDP-treated mice were tested for their cytostatic activity for tumor cell proliferation. Both substances are able to activate macrophages either after intravenous injecti...

    M. Bruley-Rosset, I. Florentin, G. Mathé in Molecular and Cellular Biochemistry (1981)

  7. No Access

    Chapter

    Macrophage activation by tuftsin and muramyl-dipeptide

    Peritoneal macrophages from tuftsin or MDP-treated mice were tested for their cytostatic activity for tumor cell proliferation. Both substances are able to activate macrophages either after intravenous injecti...

    M. Bruley-Rosset, I. Florentin, G. Mathé in Immunologically Active Peptides (1981)

  8. No Access

    Chapter and Conference Paper

    In Vivo Immunostimulating Properties of Two Retinoids: Ro 10-9359 and Ro 13-6298

    Vitamin A and some synthetic derivatives exhibit numerous activities; they have been recognized as an important factor in the differentiation of epithelial tissues (12,13); they possess an antiproliferative ef...

    Th. Hercend, M. Bruley-Rosset, I. Florentin, G. Mathé in Retinoids (1981)

  9. No Access

    Chapter

    Modification of antibody responses during non-specific acute inflammation (Abstract)

    It has been previously shown that non-specific acute inflammatory reactions are able to modify the activity of lymphocytes and macrophages. In the present work we investigated whether such a reaction could int...

    I. Florentin, M. Pelletier, G. Mathe in Inflammation: Mechanisms and Treatment (1980)

  10. No Access

    Chapter

    Modulation of Tumor Growth and Metastasis by an Acute Inflammation

    Many studies have led to the conclusion that macrophage can contribute in a variety of ways to host resistance against tumors. Non immune inflammation represents the major mechanism by which indirect activatio...

    D. Nolibe, I. Florentin, M. Pelletier, R. Masse, J. P. Giroud in Metastasis (1980)

  11. No Access

    Chapter

    Progress in Experimental Systemic Active Immunotherapy of Cancer

    A short review is presented of animal models used in cancer immunotherapy. Attention is focused on spontaneous canine tumors submitted to active immunotherapy after surgery, and on the use of immunorestoring a...

    G. Mathé, I. Florentin, M. Bruley-Rosset, N. Kiger in Cancer Chemo- and Immunopharmacology (1980)

  12. No Access

    Chapter

    Correction of Immunodeficiency in Aged Mice by Levamisole and Bestatin Administration

    An attempt to correct the impaired immune functions of aged mice was made by injecting repeatedly (over a 6-month period) two chemically defined immunostimu-lating agents, levamisole and bestatin, into 12- to ...

    M. Bruley-Rosset, I. Florentin, N. Kiger in Cancer Chemo- and Immunopharmacology (1980)

  13. No Access

    Chapter

    In Vivo Immunomodulating Properties of Two Synthetic Agents: Azimexon and Tuftsin

    Mice were submitted to various immunologic tests at different times after a single intravenous (IV) injection of azimexon or tuftsin in order to determine the mode of action of these chemically defined immunom...

    I. Florentin, J. Schulz, M. Bruley-Rosset, N. Kiger in Cancer Chemo- and Immunopharmacology (1980)

  14. No Access

    Chapter

    Effect of an acute inflammatory process on tumour development

    Since the pioneer work of Metchnikoff it has become well established that a non-immunological inflammation can increase host resistance against infection1. However, little is known about the efffect of such an in...

    D. Nolibe, I. Florentin, M. Pelletier, R. Masse in Inflammation: Mechanisms and Treatment (1980)

  15. No Access

    Chapter

    Third Generation of Systemic Adjuvants of Immunity: Experimental Basis for Adjuvant Combinations

    We already discussed in another paper in this Volume the rational experimental and clinical basis of specific and nonspecific immunotherapy [15]. We have compared the respective value of BCG and that of agents...

    G. Mathé, I. Florentin, J. I. Schulz in Adjuvant Therapies and Markers of Post-Sur… (1979)

  16. No Access

    Chapter

    Post-Surgical Systematic Active Immunotherapy: Rational and Experimental Basis

    Those who accepted the preliminary results of postsurgical chemotherapy of minimal residual disease (MRD) with too much enthusiasm now feel deceived since the number of beneficial chemotherapy trials has not i...

    G. Mathé, L. Olsson, I. Florentin, N. Kiger in Adjuvant Therapies and Markers of Post-Sur… (1979)

  17. No Access

    Article

    In vivo immunostimulation by tuftsin

    Tuftsin, a physiological basic tetrapeptide known for its capacity to stimulate the phagocytic activity of macrophages and polymorphonuclear leucocytes, was examined for its immunostimulating properties when i...

    I. Florentin, M. Bruley-Rosset, N. Kiger, J. L. Imbach in Cancer Immunology, Immunotherapy (1978)

  18. No Access

    Chapter

    The E(AkR)-Leukemia as Murine Model of Human Acute Lymphoid Leukemia for Immunotherapy Trials

    Effectiveness of active immunotherapy with systemic administration of BCG has been confirmed in many animal tumor systems as well as in the treatment of acute lymphocytic leukemias and melanomas (reviewed by M...

    L. Olsson, I. Florentin, N. Kiger, G. Mathé in Experimental Hematology Today (1977)

  19. No Access

    Chapter and Conference Paper

    The E(AkR)-Leukemia as Murine Model of Human Acute Lymphoid Leukemia for Immunotherapy Trials

    Effectiveness of active immunotherapy with systemic administration of BCG has been confirmed in many animal tumor systems as well as in the treatment of acute lymphocytic leukemias and melanomas (reviewed by M...

    L. Olsson, I. Florentin, N. Kiger, G. Mathé in Experimental Hematology Today (1977)

  20. No Access

    Article

    Experimental basis of BCG systemic immunotherapy

    I. Florentin in Cancer Immunology, Immunotherapy (1976)

previous disabled Page of 2